{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T19:11:00Z","timestamp":1677697860543},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1472-6874-13-42","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T19:20:32Z","timestamp":1382728832000},"source":"Crossref","is-referenced-by-count":8,"title":["The M-OVIN study: does switching treatment to FSH and \/ or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate \u2013 a randomised controlled trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Marleen J","family":"Nahuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke S","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulco","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G","family":"Hompes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jur","family":"Oosterhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils B","family":"Lambalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper MJ","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolien AM","family":"Koks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron JT","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joop SE","family":"Laven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J","family":"Cohlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique J","family":"Goverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie H","family":"Gerards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole F","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizka CM","family":"Nekrui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse AJ","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik A","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"517_CR1","first-page":"19","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81: 19-25.","journal-title":"Fertil Steril"},{"key":"517_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","volume":"3","author":"E Kousta","year":"1997","unstructured":"Kousta E, White DM, Franks S: Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 1997, 3: 359-365. 10.1093\/humupd\/3.4.359.","journal-title":"Hum Reprod Update"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/GCO.0b013e3280c60c9a","volume":"19","author":"S Kafy","year":"2007","unstructured":"Kafy S, Tulandi T: New advances in ovulation induction. Curr Opin Obstet Gynecol. 2007, 19: 248-252. 10.1097\/GCO.0b013e3280c60c9a.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"517_CR4","doi-asserted-by":"crossref","unstructured":"Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E: Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev. 2009, Issue 4","DOI":"10.1002\/14651858.CD002249.pub4"},{"key":"517_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0015-0282(16)35947-7","volume":"17","author":"DW Cudmore","year":"1966","unstructured":"Cudmore DW, Tupper WRC: Induction of ovulation with clomiphene citrate. Fertil Steril. 1966, 17: 363-373.","journal-title":"Fertil Steril"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0015-0282(16)48915-6","volume":"44","author":"CR Garcia","year":"1985","unstructured":"Garcia CR, Freeman EW, Rickels K, et al: Behavioral and emotional factors and treatment responses in a study of anovulatory infertile women. Fert Steril. 1985, 44: 478-483.","journal-title":"Fert Steril"},{"key":"517_CR7","first-page":"265","volume":"11","author":"JE Johnson","year":"1966","unstructured":"Johnson JE, Cohen MR, Goldferb AF, et al: The efficacy of clomiphene citrate for induction of ovulation. Int J Fertil. 1966, 11: 265-270.","journal-title":"Int J Fertil"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/humrep\/den182","volume":"23","author":"E Moll","year":"2008","unstructured":"Moll E, Korevaar JC, Bossuyt PM, van der Veen F: Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?. Hum Reprod. 2008, 23: 1830-1834. 10.1093\/humrep\/den182.","journal-title":"Hum Reprod"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0015-0282(16)46033-4","volume":"37","author":"M Gysler","year":"1982","unstructured":"Gysler M, March CM, Mishell DR, Bailey E: A decade\u2019s experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril. 1982, 37: 161-167.","journal-title":"Fertil Steril"},{"key":"517_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.05.069","volume":"87","author":"N Neveu","year":"2007","unstructured":"Neveu N, Granger L, StMichel P, Lavoie HB: Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome. Fertil Steril. 2007, 87: 113-120. 10.1016\/j.fertnstert.2006.05.069.","journal-title":"Fertil Steril"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1472-6483(10)60148-4","volume":"16","author":"A Badawy","year":"2008","unstructured":"Badawy A, Allam A, Abulatta M: Extending clomiphene treatment in clomiphene-resistant women with PCOS: a randomized controlled trial. Reprod BioMed Online. 2008, 16: 825-829. 10.1016\/S1472-6483(10)60148-4.","journal-title":"Reprod BioMed Online"},{"key":"517_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1472-6483(10)61273-4","volume":"9","author":"E L\u00f3pez","year":"2004","unstructured":"L\u00f3pez E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J: Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reprod Biomed Online. 2004, 9: 382-390. 10.1016\/S1472-6483(10)61273-4.","journal-title":"Reprod Biomed Online"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/humrep\/dei042","volume":"20","author":"Homburg","year":"2005","unstructured":"Homburg: Clomiphene citrate \u2013 end of an era? A mini review. Human reproduction. 2005, 20: 2043-2051. 10.1093\/humrep\/dei042.","journal-title":"Human reproduction"},{"key":"517_CR14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/humrep\/deh319","volume":"19","author":"M van Wely","year":"2004","unstructured":"van Wely M, Bayram N, van der Veen F, Bossuyt PM: An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod. 2004, 19: 1741-1745. 10.1093\/humrep\/deh319.","journal-title":"Hum Reprod"},{"key":"517_CR15","first-page":"1827","volume-title":"Hum Reprod","author":"M Van Wely","year":"2005","unstructured":"Van Wely M, Bayram N, Van Der Veen F, Bossuyt PM: Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome. Hum Reprod. 2005, 1827-1832."},{"key":"517_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/bmj.328.7433.192","volume":"328","author":"N Bayram","year":"2004","unstructured":"Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F: Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ. 2004, 328: 192-10.1136\/bmj.328.7433.192.","journal-title":"BMJ"},{"key":"517_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.02.026","volume":"84","author":"N Bayram","year":"2005","unstructured":"Bayram N, van Wely M, van der Veen F, Bossuyt PM, Nieuwkerk P: Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril. 2005, 84: 420-425. 10.1016\/j.fertnstert.2005.02.026.","journal-title":"Fertil Steril"},{"key":"517_CR18","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/bmj.38867.631551.55","volume":"4","author":"E Moll","year":"2006","unstructured":"Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F: Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006, 4: 1485.","journal-title":"BMJ"},{"key":"517_CR19","first-page":"196","volume":"62","author":"MG Hammond","year":"1983","unstructured":"Hammond MG, Halme JK, Talbert LM: Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol. 1983, 62: 196-202.","journal-title":"Obstet Gynecol"},{"key":"517_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994, 331: 771-776. 10.1056\/NEJM199409223311204.","journal-title":"N Engl J Med"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0015-0282(16)54473-2","volume":"56","author":"JM Randall","year":"1991","unstructured":"Randall JM, Templeton A: Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991, 56: 208-212.","journal-title":"Fertil Steril"},{"key":"517_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0015-0282(16)55855-5","volume":"59","author":"RP Dickey","year":"1993","unstructured":"Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM: Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993, 59: 756-760.","journal-title":"Fertil Steril"},{"key":"517_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1472-6483(10)60505-6","volume":"8","author":"EM Kolibianakis","year":"2004","unstructured":"Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, et al: Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online. 2004, 8: 115-118. 10.1016\/S1472-6483(10)60505-6.","journal-title":"Reprod Biomed Online"},{"key":"517_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group: Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008, 89: 505-522.","journal-title":"Fertil Steril"},{"key":"517_CR25","volume-title":"Cochrane Database Syst Rev","author":"N Bayram","year":"2001","unstructured":"Bayram N, van Wely M, van der Veen F: Recombinant versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2001"},{"key":"517_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GRF.0b013e31802f361e","volume":"50","author":"DS Guzick","year":"2007","unstructured":"Guzick DS: Ovulation induction management of PCOS. Clin Obstet Gynecol. 2007, 50: 255-267. 10.1097\/GRF.0b013e31802f361e.","journal-title":"Clin Obstet Gynecol"},{"key":"517_CR27","unstructured":"Nice guideline. See. http:\/\/www.nice.org.uk\/nicemedia\/live\/10936\/29269\/29269.pdf ."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-13-42\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T09:58:44Z","timestamp":1564567124000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-13-42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-13-42","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]},"article-number":"42"}}